VNDA: VANDA PHARMACEUTICALS INC Real-Time Headlines

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 14 hrs, 39 mins

Symbol	Value	Change	Percentage Change
DJIA	10,023.42	17.46	0.17%
NASDAQ	2,112.44	7.12	0.34%
S&P 500	1,069.30	2.67	0.25%

Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Learn More

Get the FREE DailyFinance iPhone application

VANDA PHARMACEUTICALS INC

VNDA

Stock price

10.44 0.17 1.66%

as of 04:00 PM EST on 11/06/2009 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

10.44 0.00 0.00%

as of 04:13 PM EST on 11/06/09

Analyst Consensus

Strong Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts

VANDA PHARMACEUTICALS INC Real-Time Headlines

Customize
Wednesday, November 4, 2009

SEC Filing: Quarterly Financials

11/4/09 View all Related Articles > | Thomson Financial

Tuesday, November 3, 2009

Vanda's Fanapt should reach pharmacy shelves next year, Washington Post says

11/3/09 | Theflyonthewall.com

Monday, November 2, 2009

Vanda Pharmaceuticals Reports Third Quarter 2009 Results

11/2/09 View all Related Articles > | PharmaLive

Vanda Pharma (VNDA) Tops by 3c, Posts Q3 Loss of $0.28

11/2/09 | StreetInsider.com

Vanda Pharmaceuticals reports Q3 EPS (28c) vs. consensus of (31c)

11/2/09 | Theflyonthewall.com

Vanda Pharmaceuticals Reports Third Quarter 2009 Results

11/2/09 | PR Newswire

Wednesday, October 28, 2009

Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009

10/28/09 View all Related Articles > | StockWatch

Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009

10/28/09 | PR Newswire

These Stocks Can Always Outperform

10/28/09 | The Motley Fool

Thursday, October 22, 2009

Novartis CEO on Earnings

10/22/09 | CNBC Video

Thursday, October 15, 2009

SEC Filing: Insider Buy/Sell

10/15/09 View all Related Articles > | Thomson Financial

Wednesday, October 14, 2009

Vanda Pharmaceuticals obtained impressive partner and deal terms, says Caris

10/14/09 | Theflyonthewall.com

Tuesday, October 13, 2009

Novartis Pharma AG Acquires Exclusive Rights From Vanda Pharmaceuticals, Inc. for Commercialization of Fanapt in the United States and Canada; to Pay $200 Million Upfront

10/13/09 View all Related Articles > | Pharm Country

Novartis to Develop Vanda Schizophrenia Drug

10/13/09 | CNBC Video

Vanda's Fanapt Deal Just Okay: BioBuzz

10/13/09 | TheStreet.com

Top Day Trader Alert Stocks (CIT, C, GS, JNJ, NVAX, VNDA, VASC)

10/13/09 | 24/7 Wall Street

Vanda Pharmaceuticals to host conference call

10/13/09 | Theflyonthewall.com

Titan Pharma entitled to royalties under Vanda, Novartis deal

10/13/09 | Theflyonthewall.com

Monday, October 12, 2009

Novartis Pharma Acquires Exclusive Rights From Vanda Pharmaceuticals for Commercialization of Fanapt™ in the United States and Canada

10/12/09 | Business Wire

Vanda Pharmaceuticals enters license agreement with Novartis

10/12/09 | Theflyonthewall.com

Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia

10/12/09 | PR Newswire

Thursday, October 1, 2009

Vanda Pharma October volatility elevated at 129

10/1/09 | Theflyonthewall.com

Wednesday, September 30, 2009

You’d Be Stupid to Buy These Stocks

9/30/09 | The Motley Fool

Monday, September 28, 2009

Fearful Stocks for Greedy Investors

9/28/09 | The Motley Fool

Friday, September 25, 2009

Dendreon Makes The List...Again

9/25/09 | CNBC Blogs

Tuesday, September 22, 2009

Tomorrow's Monster Stock?

9/22/09 | The Motley Fool

Tuesday, September 15, 2009

Bullish Case for Vanda Loses Steam

9/15/09 | TheStreet.com

Friday, September 4, 2009

Weighing Arena's Obesity Drug: Biotech Mailbag

9/4/09 | TheStreet.com

Monday, August 31, 2009

SEC Filing: Insider Buy/Sell

8/31/09 View all Related Articles > | Thomson Financial

Friday, August 28, 2009

SEC Filing: Insider Buy/Sell

8/28/09 | Thomson Financial

Tuesday, August 11, 2009

Vanda, Oculus, Sequenom: Biotech Notebook

8/11/09 | TheStreet.com

Monday, August 10, 2009

SEC Filing: Current Event

8/10/09 View all Related Articles > | Thomson Financial

Vanda Pharmaceuticals Reports Second Quarter 2009 Results ; FDA GRANTS U.S. MARKETING APPROVAL OF FANAPT(TM) (ILOPERIDONE)

8/10/09 View all Related Articles > | Solid State Technology

Heritage Commerce, General Steel Holdings and Vanda Pharmaceuticals lead small-cap percentage losers

8/10/09 | SmallCapInvestor

Earnings roundup: Dynegy, Carrizo Oil&Gas

8/10/09 | AP ONLINE

Vanda Pharmaceuticals Reports Second Quarter 2009 Results

8/10/09 | PR Newswire

Thursday, August 6, 2009

Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009

8/6/09 View all Related Articles > | StockWatch

Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009

8/6/09 | PR Newswire

Thursday, July 23, 2009

Analysts: Vanda Pharma ripe for buyout

7/23/09 | Fierce Biotech

Tuesday, July 21, 2009

SEC Filing: Insider Buy/Sell

7/21/09 View all Related Articles > | Thomson Financial

1 <Next>
Wednesday, November 4, 2009

SEC Filing: Quarterly Financials

11/4/09 View all News Related Articles > | Thomson Financial

Tuesday, November 3, 2009

Vanda's Fanapt should reach pharmacy shelves next year, Washington Post says

11/3/09 | Theflyonthewall.com

Monday, November 2, 2009

Vanda Pharmaceuticals reports Q3 EPS (28c) vs. consensus of (31c)

11/2/09 | Theflyonthewall.com

Deal for schizophrenia drug Fanapt 13 years in making for Vanda Pharmaceuticals

11/2/09 | The Washington Post - Washington DC

Wednesday, October 28, 2009

Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009

10/28/09 | StockHouse

These Stocks Can Always Outperform

10/28/09 | The Motley Fool

Thursday, October 22, 2009

Novartis CEO on Earnings

10/22/09 | CNBC Video

Thursday, October 15, 2009

SEC Filing: Insider Buy/Sell

10/15/09 View all News Related Articles > | Thomson Financial

Wednesday, October 14, 2009

Vanda Pharmaceuticals obtained impressive partner and deal terms, says Caris

10/14/09 | Theflyonthewall.com

Tuesday, October 13, 2009

Novartis to Develop Vanda Schizophrenia Drug

10/13/09 | CNBC Video

Vanda's Fanapt Deal Just Okay: BioBuzz

10/13/09 | TheStreet.com

Vanda Pharmaceuticals to host conference call

10/13/09 | Theflyonthewall.com

Titan Pharma entitled to royalties under Vanda, Novartis deal

10/13/09 | Theflyonthewall.com

Monday, October 12, 2009

Novartis Pharma Acquires Exclusive Rights From Vanda Pharmaceuticals for Commercialization of Fanapt(TM) in the United States and Canada

10/12/09 View all News Related Articles > | StockHouse

Vanda Pharmaceuticals enters license agreement with Novartis

10/12/09 | Theflyonthewall.com

Thursday, October 1, 2009

Vanda Pharma October volatility elevated at 129

10/1/09 | Theflyonthewall.com

Wednesday, September 30, 2009

You’d Be Stupid to Buy These Stocks

9/30/09 | The Motley Fool

Monday, September 28, 2009

Fearful Stocks for Greedy Investors

9/28/09 | The Motley Fool

Tuesday, September 22, 2009

Tomorrow's Monster Stock?

9/22/09 | The Motley Fool

Tuesday, September 15, 2009

Bullish Case for Vanda Loses Steam

9/15/09 | TheStreet.com

Friday, September 4, 2009

Weighing Arena's Obesity Drug: Biotech Mailbag

9/4/09 | TheStreet.com

Monday, August 31, 2009

SEC Filing: Insider Buy/Sell

8/31/09 View all News Related Articles > | Thomson Financial

Friday, August 28, 2009

SEC Filing: Insider Buy/Sell

8/28/09 | Thomson Financial

Tuesday, August 11, 2009

Vanda, Oculus, Sequenom: Biotech Notebook

8/11/09 | TheStreet.com

Monday, August 10, 2009

SEC Filing: Current Event

8/10/09 View all News Related Articles > | Thomson Financial

Earnings roundup: Dynegy, Carrizo Oil&Gas

8/10/09 | AP ONLINE

Vanda Pharma Reports Narrower Q2 Loss - Update

8/10/09 | RTTNews

Tuesday, July 21, 2009

SEC Filing: Insider Buy/Sell

7/21/09 View all News Related Articles > | Thomson Financial

Monday, July 20, 2009

Overnight Triple! Yee Haw!

7/20/09 View all News Related Articles > | The Motley Fool

Monday, July 13, 2009

SEC Filing: Proxy Statement

7/13/09 | Thomson Financial

Tuesday, July 7, 2009

SEC Filing: Greater than or Equal to 5% Acquisition

7/7/09 | Thomson Financial

Sunday, July 5, 2009

These Stocks Can Easily Double Your Money

7/5/09 | The Motley Fool

Thursday, June 25, 2009

5 Stocks Ready to Bounce Back

6/25/09 | The Motley Fool

Friday, June 19, 2009

Stock Search: Bank of America, General Electric

6/19/09 | TheStreet.com

1-Star Stocks Poised to Plunge: Vanda?

6/19/09 | The Motley Fool

Thursday, June 18, 2009

Four Must-See Charts: Biotech Stocks

6/18/09 | TheStreet.com

Biotech Long Shots

6/18/09 | TheStreet.com

Friday, June 12, 2009

What I'm Shorting

6/12/09 | TheStreet.com

Wednesday, June 10, 2009

These 5 Underdogs Are No Dogs

6/10/09 | The Motley Fool

Monday, June 8, 2009

SEC Filing: Greater than or Equal to 5% Acquisition

6/8/09 View all News Related Articles > | Thomson Financial

1 <Next>
Monday, November 2, 2009

Vanda Pharmaceuticals Reports Third Quarter 2009 Results

11/2/09 View all Trade Related Articles > | PharmaLive

Wednesday, October 28, 2009

Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009

10/28/09 View all Trade Related Articles > | StockWatch

Tuesday, October 13, 2009

Novartis Pharma AG Acquires Exclusive Rights From Vanda Pharmaceuticals, Inc. for Commercialization of Fanapt in the United States and Canada; to Pay $200 Million Upfront

10/13/09 View all Trade Related Articles > | Pharm Country

Monday, August 10, 2009

Vanda Pharmaceuticals Reports Second Quarter 2009 Results ; FDA GRANTS U.S. MARKETING APPROVAL OF FANAPT(TM) (ILOPERIDONE)

8/10/09 View all Trade Related Articles > | Solid State Technology

Heritage Commerce, General Steel Holdings and Vanda Pharmaceuticals lead small-cap percentage losers

8/10/09 | SmallCapInvestor

Thursday, August 6, 2009

Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009

8/6/09 | StockWatch

Thursday, July 23, 2009

Analysts: Vanda Pharma ripe for buyout

7/23/09 | Fierce Biotech

Friday, May 29, 2009

Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders

5/29/09 View all Trade Related Articles > | The Pink Sheet Daily

Friday, May 15, 2009

Fuqi International, Vanda Pharmaceuticals and Nektar Therapeutics lead small-cap volume in pre-market

5/15/09 | SmallCapInvestor

Thursday, May 14, 2009

Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting

5/14/09 View all Trade Related Articles > | The Pink Sheet Daily

Wednesday, May 13, 2009

Vanda Pharmaceuticals, Lannett and Walter Investment Management among 52-week highs

5/13/09 | SmallCapInvestor

Monday, May 11, 2009

D&E Communications, Transcept Pharmaceuticals and Vanda Pharmaceuticals lead small-cap percentage gainers

5/11/09 View all Trade Related Articles > | SmallCapInvestor

FDA Approves Vanda Pharmaceuticals' Fanapt™ For The Treatment Of Schizophrenia

5/11/09 | Pharmaceutical Online

Thursday, May 7, 2009

Vanda Pharmaceuticals, Inc. Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by

5/7/09 View all Trade Related Articles > | Pharm Country

An Extreme FDA Trade that Paid: Vanda Pharma (NASDAQ:VNDA)

5/7/09 | PR-inside - Austria

Wednesday, April 29, 2009

Vanda Pharmaceuticals, Inc. Trims Loss to $6.5 Million

4/29/09 View all Trade Related Articles > | Pharm Country

Tuesday, February 24, 2009

Vanda Pharmaceuticals, Inc. to Fight Shareholder Liquidation Proposal

2/24/09 View all Trade Related Articles > | Pharm Country

Monday, February 23, 2009

Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP

2/23/09 View all Trade Related Articles > | StockWatch

Wednesday, February 11, 2009

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results

2/11/09 View all Trade Related Articles > | StockWatch

Monday, December 1, 2008

Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet

12/1/08 View all Trade Related Articles > | The Pink Sheet Daily

Thursday, November 20, 2008

FDA Accepts Vanda Pharmaceuticals, Inc. Iloperidone Resubmission and Sets New Action Date

11/20/08 View all Trade Related Articles > | Pharm Country

Friday, October 31, 2008

Vanda Pharmaceuticals suspends development, cuts staff [Baltimore Business News - Local Baltimore News | Baltimore Business Journal]

10/31/08 View all Trade Related Articles > | Mass High Tech

Thursday, October 30, 2008

Vanda Pharmaceuticals, Inc. Q3 Loss Narrows; Job Cuts and Suspends Development Activities

10/30/08 View all Trade Related Articles > | Pharm Country

Thursday, September 25, 2008

Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights

9/25/08 View all Trade Related Articles > | StockWatch

Thursday, September 11, 2008

Vanda Pharmaceuticals, Inc. Provides Update on Iloperidone; Shares Rise on Plans for FDA Response

9/11/08 View all Trade Related Articles > | Pharm Country

Tuesday, August 5, 2008

Vanda Pharmaceuticals Reports Second Quarter 2008 Results

8/5/08 View all Trade Related Articles > | StockWatch

Thursday, July 31, 2008

Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008

7/31/08 View all Trade Related Articles > | PharmaLive

Wednesday, July 30, 2008

FDA Issues Not Approvable Letter for Iloperidone to Vanda Pharmaceuticals

7/30/08 | Pharmaceutical Processing

FDA Issues Not Approvable Letter For Iloperidone For The Treatment Of Schizophrenia To Vanda Pharmaceuticals

7/30/08 View all Trade Related Articles > | Medical News Today - UK

Friday, June 27, 2008

Vanda Pharmaceuticals, Inc. (VNDA) Says Insomnia Drug Trial Meets Main Goal

6/27/08 View all Trade Related Articles > | Biocompare

Monday, June 9, 2008

LabCorp signs collaboration agreement with Vanda Pharmaceuticals

6/9/08 | Datamonitor

Thursday, May 22, 2008

Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference

5/22/08 View all Trade Related Articles > | StockWatch

Thursday, May 8, 2008

Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference

5/8/08 View all Trade Related Articles > | The Pink Sheet Daily

Wednesday, May 7, 2008

Vanda Pharmaceuticals, Inc. Data Presented at the Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events

5/7/08 View all Trade Related Articles > | BioSpace

Tuesday, May 6, 2008

Vanda Pharmaceuticals, Eresearchtechnology and Fuel Tech lead small-cap volume in pre-market

5/6/08 | SmallCapInvestor

Monday, May 5, 2008

Vanda Pharmaceuticals, RRSat Global Communications Network and Libbey Inc among 52-week lows

5/5/08 | SmallCapInvestor

Vanda Pharmaceuticals, Vision Sciences and Transact Technologies among 52-week highs

5/5/08 | SmallCapInvestor

Vanda Pharmaceuticals, Broadway Financial and Habersham Bancorp lead small-cap percentage gainers

5/5/08 | SmallCapInvestor

Thursday, May 1, 2008

Vanda Pharma posts narrower-than-expected Q1 loss

5/1/08 | smallcapcenter.com

Vanda Pharmaceuticals Reports First Quarter 2008 Results

5/1/08 View all Trade Related Articles > | StockWatch

1 <Next>
Tuesday, October 13, 2009

Vanda Pharmaceuticals licenses schizophrenia drug for $200M

10/13/09 View all Regional Related Articles > | Baltimore Business Journal - Baltimore MD

Monday, August 10, 2009

Vanda Pharmaceuticals loses $12.4M

8/10/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Thursday, May 14, 2009

Execs sell Vanda Pharmaceuticals stock

5/14/09 | Washington Business Journal - Washington DC

Thursday, May 7, 2009

Vanda Pharmaceuticals wins drug approval, stock soars

5/7/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Wednesday, April 29, 2009

Vanda Pharmaceuticals trims loss to $6.5M

4/29/09 | Washington Business Journal - Washington DC

Friday, February 20, 2009

Shareholder wants Vanda Pharmaceuticals to shut down

2/20/09 | Baltimore Business Journal - Baltimore MD

Wednesday, February 11, 2009

Vanda Pharmaceuticals narrows loss

2/11/09 | Washington Business Journal - Washington DC

Thursday, December 18, 2008

Vanda Pharmaceuticals cuts half its staff

12/18/08 | Washington Business Journal - Washington DC

Thursday, November 20, 2008

Vanda Pharmaceuticals takes second shot at FDA approval

11/20/08 | Washington Business Journal - Washington DC

Friday, October 31, 2008

Vanda Pharmaceuticals suspends development, cuts staff

10/31/08 | Baltimore Business Journal - Baltimore MD

Tuesday, August 5, 2008

Vanda Pharmaceuticals narrows losses

8/5/08 View all Regional Related Articles > | Washington Business Journal - Washington DC

Monday, July 28, 2008

FDA rejects Vanda Pharmaceuticals drug

7/28/08 View all Regional Related Articles > | Washington Business Journal - Washington DC

Friday, May 2, 2008

Vanda Pharma. soars after narrower-than-expected 1Q loss

5/2/08 | The Boston Globe - Boston MA

Thursday, November 8, 2007

Vanda Pharmaceuticals expects to narrow its full-year loss as it works to launch iliperidone

11/8/07 View all Regional Related Articles > | CBS - KDKA 2 - Pittsburgh PA

1
Monday, November 2, 2009

Vanda Pharmaceuticals Reports Third Quarter 2009 Results

11/2/09 | PR Newswire

Wednesday, October 28, 2009

Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009

10/28/09 | PR Newswire

Monday, October 12, 2009

Novartis Pharma Acquires Exclusive Rights From Vanda Pharmaceuticals for Commercialization of Fanapt™ in the United States and Canada

10/12/09 | Business Wire

Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia

10/12/09 | PR Newswire

Monday, August 10, 2009

Vanda Pharmaceuticals Reports Second Quarter 2009 Results

8/10/09 | PR Newswire

Thursday, August 6, 2009

Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009

8/6/09 | PR Newswire

Friday, May 29, 2009

Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders

5/29/09 | PR Newswire

Thursday, May 14, 2009

Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting

5/14/09 | PR Newswire

Friday, May 8, 2009

Markets Respond to Banks' Stress Tests; Trading Spurred by News Releases and Updates - Stock Alerts on: CPKI, HOTT, VNDA, BJ, CTIC, JNPR; Issued by Beacon Equity

5/8/09 | PR Newswire

Thursday, May 7, 2009

Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital

5/7/09 | PR Newswire

Wednesday, May 6, 2009

Titan Announces FDA Approval of Fanapt™ (Iloperidone) For the Treatment of Schizophrenia

5/6/09 | Business Wire

FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia

5/6/09 | PR Newswire

Wednesday, April 29, 2009

Vanda Pharmaceuticals Reports First Quarter 2009 Results

4/29/09 | PR Newswire

Monday, February 23, 2009

Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP

2/23/09 | PR Newswire

Wednesday, February 11, 2009

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results

2/11/09 | PR Newswire

Monday, December 1, 2008

Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet

12/1/08 | PR Newswire

Thursday, November 20, 2008

FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date

11/20/08 | PR Newswire

Thursday, October 30, 2008

Vanda Pharmaceuticals Reports Third Quarter 2008 Results

10/30/08 | PR Newswire

Thursday, September 11, 2008

Live Updates:

Ticker

Dynamic view of the market

VANDA PHARMACEUTICALS INC

VNDA

Stock price

Extended Hours

VANDA PHARMACEUTICALS INC Real-Time Headlines

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, November 2, 2009

Wednesday, October 28, 2009

Thursday, October 22, 2009

Thursday, October 15, 2009

Wednesday, October 14, 2009

Tuesday, October 13, 2009

Monday, October 12, 2009

Thursday, October 1, 2009

Wednesday, September 30, 2009

Monday, September 28, 2009

Friday, September 25, 2009

Tuesday, September 22, 2009

Tuesday, September 15, 2009

Friday, September 4, 2009

Monday, August 31, 2009

Friday, August 28, 2009

Tuesday, August 11, 2009

Monday, August 10, 2009

Thursday, August 6, 2009

Thursday, July 23, 2009

Tuesday, July 21, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, November 2, 2009

Wednesday, October 28, 2009

Thursday, October 22, 2009

Thursday, October 15, 2009

Wednesday, October 14, 2009

Tuesday, October 13, 2009

Monday, October 12, 2009

Thursday, October 1, 2009

Wednesday, September 30, 2009

Monday, September 28, 2009

Tuesday, September 22, 2009

Tuesday, September 15, 2009

Friday, September 4, 2009

Monday, August 31, 2009

Friday, August 28, 2009

Tuesday, August 11, 2009

Monday, August 10, 2009

Tuesday, July 21, 2009

Monday, July 20, 2009

Monday, July 13, 2009

Tuesday, July 7, 2009

Sunday, July 5, 2009

Thursday, June 25, 2009

Friday, June 19, 2009

Thursday, June 18, 2009

Friday, June 12, 2009

Wednesday, June 10, 2009

Monday, June 8, 2009

Monday, November 2, 2009

Wednesday, October 28, 2009

Tuesday, October 13, 2009

Monday, August 10, 2009